GeneDx Holdings Corp. - Common Stock (WGS)

CUSIP: 81663L200

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
+3,149,039
Put/Call ratio
130%
SEC-reported price per share
$92.31
Number of holders
227
Value change
+$295,483,780
Number of buys
139
Open additional details 1 more signal available
Number of sells
110
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
28,736,767

Security key

81663L200

Report period

Q2 2025

Institutions

227

Top holders

10

Ownership snapshot

Top reported holders of WGS - GeneDx Holdings Corp. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ICAHN SCHOOL OF MEDICINE ...
Disclosed value leader
Casdin Capital, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
3/4/5 13D/G 13F Lead comparable stake: 4.9% 13D/G row: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Showing 1-6 of 15 holder rows.

Quick read

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI leads the comparable SEC ownership view at 4.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI's linked filing trail.
Comparable ownership Top 5
ICAHN SCHOOL OF MEDICINE AT MOUNT... 4.9%
GOLDMAN SACHS GROUP INC 3.9%
SUMMIT PARTNERS PUBLIC ASSET MANA... 3%
FMR LLC 0.6%
Blackstone Tactical Opportunities... 0.56%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
3/4/5 13D/G
10%+ Owner
4.9%
from 13D/G
$192,487,561
2,719,692 shares
15 Nov 2024
GOLDMAN SACHS GROUP INC
13D/G 13F
THE GOLDMAN SACHS GROUP, INC. · Company
3.9%
$122,860,496
1,106,752 shares
-$34,984,913 31 Mar 2025
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
13F 13D/G
Company
3%
from 13D/G
$106,501,981
1,202,529 shares
31 Mar 2025
FMR LLC
13F 13D/G
Company
0.6%
from 13D/G
$247,446,426
2,793,953 shares
31 Mar 2025
Blackstone Tactical Opportunities Associates III - NQ L.P.
3/4/5
10%+ Owner
0.56%
$649,236
162,309 shares
29 Apr 2022
Blackstone Tactical Opportunities Fund - FD L.P.
3/4/5
10%+ Owner
0.35%
$16,752,000
100,000 shares
22 Jul 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
227
Shares
31,497,581
Rows available
227
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
223
Q2 2025 holders
227
Holder diff
4
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .